[Federal Register Volume 89, Number 217 (Friday, November 8, 2024)]
[Notices]
[Page 88780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26000]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2024-0072]


Advisory Committee on Immunization Practices; Amended Notice of 
Meeting

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces an amendment 
to the following meeting of the Advisory Committee on Immunization 
Practices (ACIP). This meeting was open to the public.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management 
Specialist, Advisory Committee on Immunization Practices, National 
Center for Immunization and Respiratory Diseases, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta, 
Georgia 30329-4027. Telephone: (404) 639-8836; Email: <a href="/cdn-cgi/l/email-protection#5514161c05153631367b323a23"><span class="__cf_email__" data-cfemail="1b5a58524b5b787f78357c746d">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the 
meeting of the Advisory Committee on Immunization Practices (ACIP); 
October 23, 2024, from 8 a.m. to 5:30 p.m., EDT, and October 24, 2024, 
from 8 a.m. to 5:30 p.m., EDT (times subject to change; see the ACIP 
website for updates: https://www.cdc.gov/vaccines/acip/index.html), in 
the original Federal Register notice.
    Notice of the virtual meeting was published in the Federal Register 
on September 30, 2024, 89 FR 79610-79611.
    The meeting notice is being amended to update the recommendation 
votes in the matters to be considered, which should read as follows:
    Matters to be Considered: The agenda will include discussions on 
chikungunya vaccines, COVID-19 vaccines, cytomegalovirus (CMV) vaccine, 
Human papillomavirus (HPV) vaccines, influenza vaccines, meningococcal 
vaccines, mpox vaccines, pneumococcal vaccines, Respiratory Syncytial 
Virus (RSV) vaccines for adults, RSV vaccines for maternal and 
pediatric populations, and the adult and child/adolescent immunization 
schedules. Recommendation votes are scheduled for COVID-19 vaccines, 
meningococcal vaccines, pneumococcal vaccines, and the adult and child/
adolescent immunization schedules. A Vaccines for Children (VFC) vote 
is scheduled for influenza vaccines and meningococcal vaccines. For 
more information on the meeting agenda, visit https://www.cdc.gov/acip/meetings/index.html.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-26000 Filed 11-7-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>